Maduck Sean bought CORT

June 1, 2026 · Form 4 insider transaction

Maduck Sean bought 25,000 shares of Corcept Therapeutics Incorporated at $8.27 per share, a transaction worth $206.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
25,000
Price
$8.27
Total value
$206.8K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after33,977
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

View the original Form 4 on SEC EDGAR